Internal Medicine · Los Angeles, CA
NPI
1477882215
Since 2009
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
505 S Virgil Ave Ste 300
Los Angeles, CA, 90020
Phone (323) 297-3269
Groups this clinician bills Medicare through
Medicare paid, 2024
$203K
3,897 services
Medicare patients, 2024
176
Average age 76
Drug cost, 2024
$2.1M
7,670 prescriptions
Company payments, 2025
$1,559
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kyoung A Kim was code 99213 (office e&m - established), 1,199 times for 152 patients. In total Kyoung A Kim billed 3,897 services in 35 codes, and Medicare paid $203K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,199 | 152 | $77.25 | $93K |
| 99214 Office E&M - Established | Office | 451 | 132 | $107.61 | $49K |
| 96361 Intravenous Infusion, Hydration | Office | 287 | 81 | $10.83 | $3,107 |
| 96360 Intravenous Infusion, Hydration | Office | 285 | 82 | $28.87 | $8,228 |
| 36415 Venipuncture Blood Collection | Office | 259 | 137 | $8.65 | $2,240 |
| 96372 Injection Administration | Office | 188 | 52 | $12.27 | $2,306 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 112 | 24 | $0.36 | $40.67 |
| 99497 Care Management/Coordination | Office | 110 | 110 | $78.28 | $8,611 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 103 | 18 | $0.75 | $77.02 |
| G0008 Administration of influenza virus vaccine | Office | 80 | 80 | $35.02 | $2,802 |
| 90653 Vaccine Product | Office | 80 | 80 | $81.82 | $6,546 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 66 | 66 | $140.33 | $9,262 |
| J7042 5% dextrose/normal saline (500 ml = 1 unit) | Office | 41 | 24 | $1.07 | $43.84 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 35 | 17 | $0.97 | $34.11 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 32 | 32 | $177.45 | $5,678 |
By year: 2022 $61K for 990 services; 2023 $205K for 4,930 services; 2024 $203K for 3,897 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 259 | 137 | $8.65 | $2,240 |
Medicare prescription drug claims, 2024
In 2024, the drug Kyoung A Kim prescribed most often to Medicare patients was Atorvastatin Calcium, with 670 prescriptions and refills. In total Kyoung A Kim wrote 7,670 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 670 | 1,827 | 244 | $3,966 |
| Farxiga Dapagliflozin Propanediol | 402 | 585 | 85 | $325K |
| Amlodipine Besylate Generic | 329 | 800 | 105 | $1,268 |
| Losartan Potassium Generic | 267 | 635 | 81 | $1,290 |
| Metformin Hcl Generic | 236 | 500 | 64 | $775 |
| Vascepa Icosapent Ethyl | 210 | 298 | 46 | $89K |
| Mounjaro Tirzepatide | 201 | 201 | 29 | $208K |
| Omeprazole Generic | 181 | 295 | 75 | $737 |
| Metoprolol Succinate Generic | 142 | 294 | 35 | $970 |
| Jardiance Empagliflozin | 139 | 215 | 27 | $125K |
| Linzess Linaclotide | 133 | 165 | 39 | $87K |
| Rosuvastatin Calcium Generic | 122 | 313 | 41 | $965 |
| Azithromycin Generic | 122 | 122 | 91 | $273 |
| Donepezil Hcl Generic | 116 | 198 | 32 | $528 |
| Creon Lipase/Protease/Amylase | 113 | 124 | 40 | $126K |
Brand drugs: 2,421 claims; generic drugs: 5,214 claims; opioid claims: 49.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kyoung A Kim $1,559 ($1,559 in general payments such as food, travel and fees) from 11 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $380.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $380 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $298 |
| Merck Sharp & Dohme LLC MRK | 9 | $259 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $167 |
| Amgen Inc. AMGN | 11 | $164 |
| Lilly USA, LLC LLY | 4 | $76.11 |
| Abbvie Inc. ABBV | 3 | $60.73 |
| Exact Sciences Corporation EXAS | 2 | $57.91 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $56.05 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $26.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.